Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Turkiye Parazitol Derg ; 41(3): 173-176, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29035248

RESUMO

A 39-year-old man who was returning from the Amazon Jungle and had no medical history presented with a furuncular lesion on his right parietal scalp. Despite receiving appropriate antimicrobial treatment, his lesion did not heal. After surgical intervention, a Dermatobia hominis larva was extracted. The human botfly D. hominis is the most common causative agent of furuncular myiasis among travelers returning from Central and South America. Surgery is the main treatment option, and secondary bacterial infection should be kept in mind.


Assuntos
Dípteros , Miíase/diagnóstico , Dermatopatias Parasitárias/diagnóstico , Adulto , Animais , Brasil , Diagnóstico Diferencial , Humanos , Larva , Masculino , Miíase/parasitologia , Miíase/cirurgia , Couro Cabeludo , Dermatopatias Parasitárias/parasitologia , Dermatopatias Parasitárias/cirurgia , Viagem
2.
Turk J Med Sci ; 46(1): 58-62, 2016 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-27511334

RESUMO

BACKGROUND/AIM: Mucormycosis is a rare invasive fungal infection most commonly encountered in the immunocompromised host. We analyzed 51 adult patients treated for mucormycosis between 2003 and 2013 and recorded at a tertiary university hospital in Turkey. MATERIALS AND METHODS: We examined the following data for all patients: age, sex, predisposing disease, symptoms, treatment, surgical procedure, concomitant infections, intensive care requirement, and outcomes. RESULTS: During the study period 51 cases of mucormycosis were documented; 54.9% of the patients were female. The mean age was 44.2 ± 18.2 years. Rhinocerebral presentation was reported in 94.1% of patients. Almost all patients (88.2%) had at least one risk factor. The common predisposing factors were hematologic malignancies (52.9%), diabetes mellitus (25.5%), and solid malignancies (5.8%). The most common initial symptoms were fever, cellulitis, and facial pain. The primary medication used was liposomal amphotericin B or conventional amphotericin B. Surgery was performed in 94.1% of patients. Mortality was 52.9%. CONCLUSION: Our study revealed that mucormycosis continues to be a mortal disease in about half of the cases. Our findings indicate that treatment with L-AMB is associated with a favorable response. Also, in the case of facial pain, the low mortality rate may indicate the importance of early diagnosis.


Assuntos
Mucormicose , Adulto , Antifúngicos , Feminino , Humanos , Hospedeiro Imunocomprometido , Masculino , Pessoa de Meia-Idade , Centros de Atenção Terciária , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA